Chen, S.-H.; Chang, T.-Y.; Wang, Y.-L.; Lee, E.-P.; Lin, J.-J.; Hsiao, Y.-W.; Jaing, T.-H.; Yang, C.-P.; Hung, I.-J.
Outcome of Tocilizumab Treatment in Febrile Neutropenic Children with Severe Sepsis/Septic Shock in a Single-Center Retrospective Case Series. Cancers 2024, 16, 1512.
https://doi.org/10.3390/cancers16081512
AMA Style
Chen S-H, Chang T-Y, Wang Y-L, Lee E-P, Lin J-J, Hsiao Y-W, Jaing T-H, Yang C-P, Hung I-J.
Outcome of Tocilizumab Treatment in Febrile Neutropenic Children with Severe Sepsis/Septic Shock in a Single-Center Retrospective Case Series. Cancers. 2024; 16(8):1512.
https://doi.org/10.3390/cancers16081512
Chicago/Turabian Style
Chen, Shih-Hsiang, Tsung-Yen Chang, Yi-Lun Wang, En-Pei Lee, Jainn-Jim Lin, Yi-Wen Hsiao, Tang-Her Jaing, Chao-Ping Yang, and Iou-Jih Hung.
2024. "Outcome of Tocilizumab Treatment in Febrile Neutropenic Children with Severe Sepsis/Septic Shock in a Single-Center Retrospective Case Series" Cancers 16, no. 8: 1512.
https://doi.org/10.3390/cancers16081512
APA Style
Chen, S. -H., Chang, T. -Y., Wang, Y. -L., Lee, E. -P., Lin, J. -J., Hsiao, Y. -W., Jaing, T. -H., Yang, C. -P., & Hung, I. -J.
(2024). Outcome of Tocilizumab Treatment in Febrile Neutropenic Children with Severe Sepsis/Septic Shock in a Single-Center Retrospective Case Series. Cancers, 16(8), 1512.
https://doi.org/10.3390/cancers16081512
